Danish diabetes and obesity giant Novo Nordisk today announced headline results from STEP UP, a Phase IIIb trial in the ...

Telix Pharmaceuticals (TLX: ASX) has announced a definitive agreement to acquire key assets from ImaginAb, a specialist in ...

The US Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), has ...

The WHO releases draft guidelines on implementing continuous manufacturing in pharmaceuticals, highlighting benefits like ...

The US Food and Drug Administration approved sotorasib (trade name Lumakras) with panitumumab Vectibix), from US biotech ...

The FDA grants AstraZeneca’s Calquence full approval for first-line mantle cell lymphoma as a combination therapy and ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

Orna Therapeutics and Shanghai Simnova expand their collaboration to develop RNA-based therapies targeting BCMA for multiple ...

German family-owned pharma major Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical ...

Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following ...

China's National Medical Products Administration (NMPA) has approved the New Drug Application (NDA) of limertinib for the ...

Even as the global diabetes war continues to rage, Indian pharmaceutical companies are emerging from the shadows, armed with ...